Lapatinib in combination with ECF/x in EGFR1 positive first-line metastatic gastric cancer (GC): A phase II randomized placebo controlled trial (EORTC 40071).
Markus Hermann Moehler
No relevant relationships to disclose
Arno Schad
No relevant relationships to disclose
Murielle E. Mauer
No relevant relationships to disclose
Michel Praet
No relevant relationships to disclose
Francisco J. Sapunar
Employment or Leadership Position - GlaxoSmithKline
Stock Ownership - GlaxoSmithKline
Kathryn Jane Briggs
Employment or Leadership Position - GlaxoSmithKline
Stock Ownership - GlaxoSmithKline
Manfred P. Lutz
No relevant relationships to disclose
Arnaud Roth
No relevant relationships to disclose